Valuation: CelLBxHealth plc

Market Cap 16.76M 22.42M 19.62M 18.08M 31.82M 2.13B 32.33M 217M 84.33M 1.05B 84.18M 82.36M 3.63B P/E 2025 *
-0.26x
P/E 2026 * -0.63x
Enterprise Value 9.46M 12.66M 11.08M 10.21M 17.96M 1.2B 18.25M 122M 47.6M 593M 47.52M 46.49M 2.05B EV / Sales 2025 *
0.91x
EV / Sales 2026 * 0.7x
Free-Float
94.31%
Yield 2025 *
-
Yield 2026 * -

Last Transcript: CelLBxHealth plc

1 day-4.71%
1 week-7.84%
Current month-7.84%
1 month-18.52%
3 months+56.17%
6 months+33.86%
Current year+27.77%
1 week 1.41
Extreme 1.4055
1.67
1 month 1.3
Extreme 1.3
2
Current year 0.85
Extreme 0.85
2.8
1 year 0.85
Extreme 0.85
8
3 years 0.85
Extreme 0.85
37.4
5 years 0.85
Extreme 0.85
163.75
10 years 0.85
Extreme 0.85
163.75
Manager TitleAgeSince
Director of Finance/CFO - 01/01/1999
Chief Tech/Sci/R&D Officer - 01/01/2025
Chief Tech/Sci/R&D Officer - 05/06/2023
Director TitleAgeSince
Chairman 67 22/05/2023
Director/Board Member 61 12/01/2026
Director/Board Member 61 12/01/2026
Date Insider Type Main position Quantity % Market Cap.
12-19Buy

Chief Financial Officer

2,500,000 0.7749%
12-19Buy

Chairman

5,000,000 1.5497%
12-19Buy

Chief Executive Officer

5,000,000 1.5497%
Change 5-day change 1-year change 3-year change Capi.($)
-4.71%-7.84%-78.38%-87.51% 22.42M
-3.23%-2.18%+3.60%-27.41% 16.54B
-3.35%+9.52%+35.27%+90.40% 1.65B
-5.53%-11.00%-47.50%-80.98% 1.16B
-0.36%+0.13%-31.02%+31.73% 1.1B
-4.07%-2.54%-28.53%-54.68% 613M
-3.14%-7.46%-39.94%-57.41% 550M
+0.52%+0.47%+27.28%-53.71% 449M
-1.11%+1.80%-55.00%-59.62% 382M
-3.07%-2.20%-26.41%-29.89% 337M
Average -2.78%-0.79%-24.06%-32.91% 2.28B
Weighted average by Cap. -3.11%+0.38%-1.33%-21.37%

Financials

2025 *2026 *
Net sales 10.35M 13.85M 12.12M 11.17M 19.66M 1.31B 19.97M 134M 52.09M 649M 52M 50.88M 2.24B 21.65M 28.96M 25.35M 23.36M 41.1M 2.75B 41.76M 280M 109M 1.36B 109M 106M 4.69B
Net income -16.35M -21.87M -19.14M -17.64M -31.04M -2.08B -31.54M -212M -82.26M -1.02B -82.12M -80.34M -3.54B -8.55M -11.44M -10.01M -9.22M -16.23M -1.09B -16.49M -111M -43.01M -536M -42.94M -42.01M -1.85B
Net Debt -7.3M -9.77M -8.55M -7.88M -13.86M -927M -14.08M -94.44M -36.73M -457M -36.66M -35.87M -1.58B -1.6M -2.14M -1.87M -1.73M -3.04M -203M -3.09M -20.7M -8.05M -100M -8.04M -7.86M -347M
Logo CelLBxHealth plc
Cellbxhealth PLC, formerly ANGLE plc, is a global precision circulating tumor cell (CTC) intelligence company specializing in innovative circulating tumor cell solutions for use in research, drug development and clinical oncology. The product portfolio comprises the Parsortix platform with associated consumables and assays. Its Parsortix platform harvests CTCs from blood and enables comprehensive downstream analysis - including whole-cell imaging, proteomic profiling and full genomic workflows - supporting research, drug development and clinical oncology. Its Parsortix PC1 system is the first FDA cleared medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for subsequent, user-validated analysis.Its Parsortix PR1 System is a semi-automated platform for epitope-independent CTC isolation, used in research and clinical trials for multiple cancer types.
Employees
119
Date Price Change Volume
08/07/26 GBX 1.406 -4.71% 2,155,742
07/07/26 GBX 1.475 -7.81% 4,128,376
06/07/26 GBX 1.600 +6.67% 2,912,628
03/07/26 GBX 1.500 0.00% 716,727
02/07/26 GBX 1.500 -1.64% 973,749
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0148GBP
Average target price
0.0400GBP
Spread / Average Target
+171.19%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CLBX Stock